Skip to content

Released Feb 26, 2013, during market hours

10-K filed Feb 26, 2013, 57 days after period end · 0001477932-13-000891

Q4 2012 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income$5.02MderivedN/M vs Q4 2011N/M vs Q3 2012
EPS, diluted—Not derived. Share counts vary by quarter.
Free Cash Flowderived-$1,039,434—

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2012derived from reported figuresQ4 2011
Net Income$5.02M-$5.16K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR